Ellume, page-6

All good questions Stockcount. All unlikely to be answered by management. They seem to have retreated back into the Cone of SIlence.
From the Half Yearly Update of 27/02/20:

• There are now 25+ organisations in "evaluation and commercial discussion phases". Really. Really?? And (apart from Merk and the Axxin sepsis test ANNs......crickets chirping in otherwise silence. WTF! Are none of these 25 "collaborations" worth revealing to the SHs? Are the details not being revealed because they have all petered out and been rejected?Just in case readers think I am being too harsh, the following was also included in the Half Yearly Update:
• "We will ensure that the market is updated regularly on the progress of this and other collaborations in the near future."....Their words; not mine! And we get crickets. Or perhaps we could conclude that there has been no progress.

Then, from the Life Sciences Update a few days later on 02/03:

• Europium particle market ready in March. Well; sales must be really taking off...not that we would know!
• IMRA's colloid gold particle "available shortly"....well is that referring to geological time, or....? Again, no update.
• Pacific Images got a mention, too. There was a "joint marketing agreement". To market what? Where? When? And what has been the result to date? How would we know?

Note to BOD: LIFT YOUR GAME, PLEASE! COMMUNICATE WITH SH!